[2]
Lazarus R,Lim PL, Avian influenza: recent epidemiology, travel-related risk, and management. Current infectious disease reports. 2015 Jan; [PubMed PMID: 25475382]
[3]
Rabadan R,Robins H, Evolution of the influenza a virus: some new advances. Evolutionary bioinformatics online. 2008 Jan 30; [PubMed PMID: 19430605]
[4]
Lai S,Qin Y,Cowling BJ,Ren X,Wardrop NA,Gilbert M,Tsang TK,Wu P,Feng L,Jiang H,Peng Z,Zheng J,Liao Q,Li S,Horby PW,Farrar JJ,Gao GF,Tatem AJ,Yu H, Global epidemiology of avian influenza A H5N1 virus infection in humans, 1997-2015: a systematic review of individual case data. The Lancet. Infectious diseases. 2016 Jul; [PubMed PMID: 27211899]
[5]
Cowling BJ,Jin L,Lau EH,Liao Q,Wu P,Jiang H,Tsang TK,Zheng J,Fang VJ,Chang Z,Ni MY,Zhang Q,Ip DK,Yu J,Li Y,Wang L,Tu W,Meng L,Wu JT,Luo H,Li Q,Shu Y,Li Z,Feng Z,Yang W,Wang Y,Leung GM,Yu H, Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet (London, England). 2013 Jul 13; [PubMed PMID: 23803488]
[6]
Qin Y,Horby PW,Tsang TK,Chen E,Gao L,Ou J,Nguyen TH,Duong TN,Gasimov V,Feng L,Wu P,Jiang H,Ren X,Peng Z,Li S,Li M,Zheng J,Liu S,Hu S,Hong R,Farrar JJ,Leung GM,Gao GF,Cowling BJ,Yu H, Differences in the Epidemiology of Human Cases of Avian Influenza A(H7N9) and A(H5N1) Viruses Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015 Aug 15; [PubMed PMID: 25940354]
[7]
Kumlin U,Olofsson S,Dimock K,Arnberg N, Sialic acid tissue distribution and influenza virus tropism. Influenza and other respiratory viruses. 2008 Sep [PubMed PMID: 19453419]
[8]
Belser JA,Lash RR,Garg S,Tumpey TM,Maines TR, The eyes have it: influenza virus infection beyond the respiratory tract. The Lancet. Infectious diseases. 2018 Jul [PubMed PMID: 29477464]
[9]
Beigel JH,Farrar J,Han AM,Hayden FG,Hyer R,de Jong MD,Lochindarat S,Nguyen TK,Nguyen TH,Tran TH,Nicoll A,Touch S,Yuen KY, Avian influenza A (H5N1) infection in humans. The New England journal of medicine. 2005 Sep 29; [PubMed PMID: 16192482]
[10]
Zhuang J,Zang N,Ye C,Xu F, Lethal avian influenza A (H5N1) virus induces ataxic breathing in mice with apoptosis of pre-Botzinger complex neurons expressing neurokinin-1 receptor. American journal of physiology. Lung cellular and molecular physiology. 2017 Nov 1 [PubMed PMID: 28729347]
[11]
Peacock THP,James J,Sealy JE,Iqbal M, A Global Perspective on H9N2 Avian Influenza Virus. Viruses. 2019 Jul 5; [PubMed PMID: 31284485]
[12]
Zhou L,Chen E,Bao C,Xiang N,Wu J,Wu S,Shi J,Wang X,Zheng Y,Zhang Y,Ren R,Greene CM,Havers F,Iuliano AD,Song Y,Li C,Chen T,Wang Y,Li D,Ni D,Zhang Y,Feng Z,Uyeki TM,Li Q, Clusters of Human Infection and Human-to-Human Transmission of Avian Influenza A(H7N9) Virus, 2013-2017. Emerging infectious diseases. 2018 Feb; [PubMed PMID: 29165238]
[13]
Chen Y,Wang D,Zheng S,Shu Y,Chen W,Cui D,Li J,Yu H,Wang Y,Li L,Shang H, Rapid diagnostic tests for identifying avian influenza A(H7N9) virus in clinical samples. Emerging infectious diseases. 2015 Jan; [PubMed PMID: 25529064]
[14]
Schünemann HJ,Hill SR,Kakad M,Bellamy R,Uyeki TM,Hayden FG,Yazdanpanah Y,Beigel J,Chotpitayasunondh T,Del Mar C,Farrar J,Tran TH,Ozbay B,Sugaya N,Fukuda K,Shindo N,Stockman L,Vist GE,Croisier A,Nagjdaliyev A,Roth C,Thomson G,Zucker H,Oxman AD, WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. The Lancet. Infectious diseases. 2007 Jan; [PubMed PMID: 17182341]
[15]
Herbinger KH,von Sonnenburg F,Nothdurft HD,Perona P,Borkowski A,Fragapane E,Nicolay U,Clemens R, A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adults. Human vaccines [PubMed PMID: 24047817]
[16]
Vaughn DW,Seifert H,Hepburn A,Dewe W,Li P,Drame M,Cohet C,Innis BL,Fries LF, Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials. Human vaccines [PubMed PMID: 25483467]
[17]
Feldstein LR,Matrajt L,Elizabeth Halloran M,Keitel WA,Longini IM Jr, Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies. Vaccine. 2016 Jul 19; [PubMed PMID: 27268778]
[18]
Khurana S,Coyle EM,Manischewitz J,King LR,Gao J,Germain RN,Schwartzberg PL,Tsang JS,Golding H, AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization. NPJ vaccines. 2018; [PubMed PMID: 30302282]
[20]
Bailey ES,Fieldhouse JK,Choi JY,Gray GC, A Mini Review of the Zoonotic Threat Potential of Influenza Viruses, Coronaviruses, Adenoviruses, and Enteroviruses. Frontiers in public health. 2018; [PubMed PMID: 29686984]